Latest filing published 07 Mar 2023 for Teva Pharmaceutical Industries Ltd.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Eli Shani: trading record in brief
All filings by Eli Shani on record concern Teva Pharmaceutical Industries Ltd, in the capacity of senior executive. The record holds 9 filings, for trades running from 28 February 2022 to 5 March 2023.
Sales make up the whole of the open-market record (1 sale, €39k). Other entries cover 8 option exercises.
The latest filing, published on 7 March 2023, reports an option exercise in Teva Pharmaceutical Industries Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eli Shani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,173 sharesOrdinary SharesSEC:0001209191-23-016719:0
- 5,311 sharesOrdinary SharesSEC:0001209191-23-014441:0
- 1,581 sharesOrdinary SharesSEC:0001209191-22-045351:0
- 3,173 sharesOrdinary SharesSEC:0001209191-22-017061:0
- 5,311 sharesOrdinary SharesSEC:0001209191-22-014474:0
5 of 5 declarations
